Comment: Introducing Neurologic Therapeutics in 2035
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published December 13, 2021.
Author Disclosures
- Lyell K. Jones Jr, MD and
- Robert A. Gross, MD, PhD
- Lyell K. Jones Jr, MD and
NONE
NONE
NONE
Neurology: Clinical Practice, Editorial Board, 2016 to present
NONE
Mayo Clinic Neurology Board Review book, Oxford University Press, 2015
NONE
NONE
NONE
Voluntary member of the AANI Board of Directors Voluntary member of the Mayo Clinic ACO Board of Directors Voluntary chair of the American Academy of Neurology Quality Committee Teaching honoraria from the American Academy of Neurology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert A. Gross, MD, PhD
NONE
NONE
Received honorarium from AAN as Editor-in-Chief of Neurology (through Q1 2020).
Served as Editor-in-Chief of Neurology 2009-2020.
NONE
Neurology in Practice (series); Blackwell-Wiley; 2011-2021
NONE
NONE
NONE
NONE
Has conducted clinical trials funded by GlaxoSmithKline, UCB, Ortho-McNeil, Pfizer, and Marinus, but has ceased participation in industry-sponsored clinical trials and speakers' bureau since appointment as EIC for Neurology (2009).
NONE
1) UL1 TR002001 Bennett/Zand (MPI) 07/15/2020 - 06/30/2025 NIH/National Center for Advancing Translational Sciences The University of RochesterÂs Clinical and Translational Science Institute $19,107,872 2% effort on Digital Health & Regulatory Science; 5% effort on the Translational Endeavors Core (ended on 12/31/2020)
UT Austin: Grand Rounds Honorarium ($500) - 2021 Stock/Stock Options, Medical Equipment & Materials: Note: All since term as editor ended 1. Amgen, 2020- 2. GSK, 2020- 3. J&J, 2020- 4. Merck, 2020- 5. Pfizer, 2020- 6. Procter & Gamble, 2020-
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg